CIK 0001412486 · Non-accelerated filer<br>Smaller reporting company
Cocrystal Pharma, Inc.
Sign in to watch- Ticker
- COCP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 352528215
- Phone
- (786) 459-1831
- Business address
- 19805 N. CREEK PARKWAY, BOTHELL, WA, 98011
- Former names
- BIOZONE PHARMACEUTICALS, INC., International Surf Resorts, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-05 | FROST PHILLIP MD ET AL Director | Purchase | +10,000 | $0.98 | $10K | 1,993,551 |
| 2026-08-03 | FROST PHILLIP MD ET AL Director | Purchase | +75,000 | $0.94 | $71K | 1,983,551 |
| 2026-06-03 | SAPIRSTEIN JAMES Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +235,000 | 235,000 | ||
| 2026-02-24 | FROST PHILLIP MD ET AL Director | Purchase | +20,000 | $1.00 | $20K | 1,908,551 |
| 2026-02-06 | FROST PHILLIP MD ET AL Director | Purchase | +50,000 | $0.95 | $47K | 1,888,551 |
| 2026-01-09 | Kornberg Roger D. Director | Grant or award · Stock Options (Right to Buy) | +24,615 | 24,615 | ||
| 2026-01-09 | PFENNIGER RICHARD C JR Director | Grant or award · Stock Options (Right to Buy) | +16,410 | 16,410 | ||
| 2026-01-09 | Lee Sam President and Co-CEO | Grant or award · Stock Options (Right to Buy) | +49,229 | 49,229 | ||
| 2026-01-09 | Hassan Fred Director | Grant or award · Stock Options (Right to Buy) | +16,410 | 16,410 | ||
| 2026-01-09 | Martin James Joseph Co-CEO and CFO | Grant or award · Stock Options (Right to Buy) | +49,229 | 49,229 | ||
| 2026-01-09 | FROST PHILLIP MD ET AL Director | Grant or award · Stock Options (Right to Buy) | +24,615 | 24,615 | ||
| 2026-01-09 | Japour Anthony J Director | Grant or award · Stock Options (Right to Buy) | +16,410 | 16,410 | ||
| 2026-01-09 | Rubin Steven D Director | Grant or award · Stock Options (Right to Buy) | +16,410 | 16,410 | ||
| 2025-12-31 | FROST PHILLIP MD ET AL Director | Purchase | +50,000 | $0.95 | $47K | 1,838,551 |
| 2025-12-30 | FROST PHILLIP MD ET AL Director | Purchase | +20,000 | $0.97 | $19K | 1,788,551 |
| 2025-12-26 | FROST PHILLIP MD ET AL Director | Purchase | +40,000 | $0.97 | $39K | 1,768,551 |
| 2025-12-24 | FROST PHILLIP MD ET AL Director | Purchase | +25,000 | $0.97 | $24K | 1,728,551 |
| 2025-11-26 | FROST PHILLIP MD ET AL Director | Purchase | +1,500 | $1.00 | $2K | 1,701,051 |
| 2025-11-26 | FROST PHILLIP MD ET AL Director | Purchase | +2,500 | $0.99 | $2K | 1,703,551 |
| 2025-11-25 | FROST PHILLIP MD ET AL Director | Purchase | +20,000 | $0.94 | $19K | 1,699,551 |
Page 1 of 8 · 145 trades